Home » Topics » Disease categories and therapies » Urology

Urology
RSS

New treatment options for urological disorders reported in recent patents

Nov. 11, 2008

Amitriptyline beneficial in benign prostatic hyperplasia

Nov. 4, 2008

FDA approves fesoterodine for overactive bladder

Nov. 3, 2008

FDA approves Kringle's IND to initiate phase I trial of recombinant human HGF in ARF

Nov. 3, 2008

Tamsulosin-tolterodine ER combination improves ureteral stent-related urinary symptoms

Nov. 3, 2008

Questcor evaluates Acthar as potential new treatment for nephrotic syndrome

Oct. 29, 2008

Flupirtine mechanism of action may be useful in treating overactive bladder

Oct. 29, 2008

Recent Takeda patent reports new 5-HT2C receptor agonists for urinary incontinence

Oct. 15, 2008

Protox presents positive 12-month data from BPH study

Oct. 10, 2008

Watson receives FDA approval for Rapaflo for benign prostatic hyperplasia

Oct. 9, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...